Work

Faculty Opinions recommendation of SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.

Year: 2021

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.739244247.793581580

Author: Yves Pommier

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4205975812

Cites:

Cited by:

Related to: 10